Ki-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

被引：0
|
作者：
Kozar, N. [1 ]
Sikosek, N. Cas [1 ]
Arko, D. [1 ]
Ravnik, M. [1 ]
Takac, I. [1 ]
机构：
[1] Univ Med Ctr Maribor, Clin Gynaecol & Perinatol, Maribor, Slovenia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0697
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [31] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2017, 96 (51)
  • [32] CHANGES IN KI-67 PROLIFERATION MARKER AFTER NEOADJUVANT THERAPY IN BREAST CANCER PATIENTS
    Chow, L. W. C.
    Yip, A. Y. S.
    Loo, W. T. Y.
    Lie, K. L. W.
    BREAST, 2013, 22 : S61 - S61
  • [33] Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
    Rapoport, B. L.
    Barnard-Tidy, J.
    Van Eeden, R. I.
    Smit, T.
    Nayler, S.
    Benn, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 37 - 37
  • [34] Breast Cancer Patients with Neoadjuvant Chemotherapy Have a Different Clinical Significance of the Ki-67 Expression before and after the Treatment
    Wada, N.
    Asaga, S.
    Yamauchi, C.
    Fujii, S.
    CANCER RESEARCH, 2010, 70
  • [35] Prognostic significance of reduction rate of Ki-67 after neoadjuvant chemotherapy in breast cancer patients with non-pCR.
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Hosono, Ako
    Itoh, Kuniaki
    Fujii, Satoshi
    Yoneyama, Kimiyasu
    Wada, Noriaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Correlation between FLT-PET and Ki-67 change in breast cancer during neoadjuvant chemotherapy
    Blackman, S. C.
    Railkar, R. A.
    Fox, R.
    George, L.
    Iannone, R.
    Bergstrom, D. A.
    Mozley, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] High Ki-67 and Vascular Endothelial Growth Factor (VEGF) Protein Expression as Negative Predictive Factor for Combined Neoadjuvant Chemotherapy in Young Age Stage III Breast Cancer
    Sudarsa, I. W.
    Tjakra, Manuaba I. B. W.
    Maliawan, Sri
    Sutirtayasa, I. W. P.
    BALI MEDICAL JOURNAL, 2016, 5 (02) : 35 - 47
  • [38] Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.
    Farr, Alex
    Weber, Myriam
    Pfeiler, Georg
    Oppolzer, Elisabeth
    Salama, Mohammed
    Bago-Horvath, Zsuzsanna
    Seifert, Michael
    Singer, Christian F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Ki-67 as a prognostic marker in patients with breast cancer
    Lux, M. P.
    Schrauder, M.
    Loehberg, C. R.
    Wiesner, F. G.
    Beckmann, M. W.
    Fasching, P. A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S57 - S57
  • [40] Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
    Kim, Ji-Yeon
    Oh, Jung Min
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    Ahn, Jin Seok
    Kim, Kyunga
    Im, Young-Hyuck
    FRONTIERS IN ONCOLOGY, 2022, 12
12345